MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS

Clinical trials for MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS explained in plain language.

Never miss a new study

Get alerted when new MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS trials appear

Sign up with your email to follow new studies for MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1 Completed 8

New hope for kids with severe skin condition in major drug trial

Disease control Ongoing

This study is testing a medication called tildrakizumab to see if it can effectively and safely control moderate-to-severe plaque psoriasis in children and teenagers aged 6 to 18. It will compare the drug against a placebo (an inactive substance) and another approved treatment. T…

Matched conditions: MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS

Phase: PHASE2, PHASE3 • Sponsor: Sun Pharmaceutical Industries Limited • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS

Get alerted when new MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS trials appear

New hope for kids with severe skin condition in major drug trial